JP2004506722A5 - - Google Patents

Download PDF

Info

Publication number
JP2004506722A5
JP2004506722A5 JP2002521433A JP2002521433A JP2004506722A5 JP 2004506722 A5 JP2004506722 A5 JP 2004506722A5 JP 2002521433 A JP2002521433 A JP 2002521433A JP 2002521433 A JP2002521433 A JP 2002521433A JP 2004506722 A5 JP2004506722 A5 JP 2004506722A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
ethoxy
oxazol
propionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002521433A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004506722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/022617 external-priority patent/WO2002016332A1/en
Publication of JP2004506722A publication Critical patent/JP2004506722A/ja
Publication of JP2004506722A5 publication Critical patent/JP2004506722A5/ja
Withdrawn legal-status Critical Current

Links

JP2002521433A 2000-08-23 2001-08-23 ペルオキシソーム増殖因子活性化受容体の調節方法 Withdrawn JP2004506722A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22745600P 2000-08-23 2000-08-23
PCT/US2001/022617 WO2002016332A1 (en) 2000-08-23 2001-08-23 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists

Publications (2)

Publication Number Publication Date
JP2004506722A JP2004506722A (ja) 2004-03-04
JP2004506722A5 true JP2004506722A5 (https=) 2008-10-09

Family

ID=22853183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002521433A Withdrawn JP2004506722A (ja) 2000-08-23 2001-08-23 ペルオキシソーム増殖因子活性化受容体の調節方法

Country Status (10)

Country Link
US (1) US7176224B2 (https=)
EP (1) EP1313717B1 (https=)
JP (1) JP2004506722A (https=)
AT (1) ATE375985T1 (https=)
AU (1) AU2001284660A1 (https=)
CA (1) CA2418134A1 (https=)
DE (1) DE60131001T2 (https=)
ES (1) ES2295200T3 (https=)
MX (1) MXPA03001610A (https=)
WO (1) WO2002016332A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004509084A (ja) 2000-08-23 2004-03-25 イーライ・リリー・アンド・カンパニー オキサゾリル−アリールオキシ酢酸誘導体およびそのpparアゴニストとしての使用
CA2418104A1 (en) 2000-08-23 2002-02-28 Eli Lilly And Company Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
HRP20031002A2 (en) * 2001-06-07 2004-06-30 Lilly Co Eli Modulators of peroxisome proliferator activated receptors (ppar)
CZ20033309A3 (cs) * 2001-06-07 2004-05-12 Eliálillyáandácompany Modulátory receptorů aktivovaných peroxizomálními proliferátory }PPARB
PT1445258E (pt) * 2001-10-12 2009-07-02 Nippon Chemiphar Co Activador para o receptor delta activado por proliferador de peroxissoma
US20050080115A1 (en) * 2002-10-28 2005-04-14 Lone Jeppesen Novel compounds, their preparation and use
CA2503117C (en) * 2002-11-08 2010-12-21 F. Hoffmann-La Roche Ag Substituted 4-alkoxyoxazol derivatives as ppar agonists
US7192970B2 (en) * 2002-11-26 2007-03-20 Chipscreen Biosciences, Ltd. Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
ES2297382T3 (es) 2003-02-14 2008-05-01 Eli Lilly And Company Derivados de sulfonamida como moduladores de ppar.
DE102004060227B3 (de) * 2004-12-15 2006-07-20 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten
US20090054435A1 (en) * 2005-07-29 2009-02-26 Hiroshi Imoto Phenoxyalkanoic Acid Compound
CN102574823B (zh) 2009-08-05 2014-09-10 第一三共株式会社 酰胺衍生物
JP5069813B2 (ja) * 2010-10-14 2012-11-07 第一三共株式会社 アシルベンゼン誘導体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
US5902726A (en) 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
AU721452B2 (en) 1996-02-02 2000-07-06 Merck & Co., Inc. Antidiabetic agents
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
CN1233241A (zh) 1996-08-19 1999-10-27 日本烟草产业株式会社 丙酸衍生物及其用途
ATE451346T1 (de) 1998-03-10 2009-12-15 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
US6417212B1 (en) * 1999-08-27 2002-07-09 Eli Lilly & Company Modulators of peroxisome proliferator activated receptors
JP4316787B2 (ja) 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
CA2418104A1 (en) * 2000-08-23 2002-02-28 Eli Lilly And Company Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
JP2004509084A (ja) 2000-08-23 2004-03-25 イーライ・リリー・アンド・カンパニー オキサゾリル−アリールオキシ酢酸誘導体およびそのpparアゴニストとしての使用

Similar Documents

Publication Publication Date Title
JP2004506722A5 (https=)
JP2009519965A5 (https=)
JP2004534824A5 (https=)
JP2013519680A5 (https=)
JP2004529174A5 (https=)
JP2006518763A5 (https=)
RU2437877C2 (ru) Новые производные тиофена в качестве агонистов рецептора s1p1/edg1
JP2007511485A5 (https=)
JP2004506721A5 (https=)
JP2004534035A5 (https=)
JP2021511360A5 (https=)
HRP20160450T1 (hr) Novi inhibitori reduktaze s-nitrozoglutationa
US20140039009A1 (en) Compounds for inflammation and immune-related uses
JP2005528348A5 (https=)
JP2019517455A5 (https=)
JP2014510132A5 (https=)
JP2007520471A5 (https=)
JP2007505916A5 (https=)
JP2010513397A5 (https=)
CA2565813A1 (en) Substituted methyl aryl or heteroaryl amide compounds
JP2008507532A5 (https=)
JP2008526866A5 (https=)
JP2005526081A5 (ja) 代謝型グルタメート受容体−5の二アリール置換テトラゾールモジュレータ
JP2007523181A5 (https=)
JP2009540009A5 (https=)